AAAAAA

   
Results: 1-25 | 26-35
Results: 1-25/35
WHICH HEMATOPOIETIC STEM-CELL TRANSPLANTATION TYPE IS SAFE FOR PATIENTS WITH HEPATITIS-B VIRUS CARRIERS
Authors: USTUN C IDILMAN R OZCAN M AKAN H KARAYALCIN S GURMAN G ILHAN O BEKSAC M UYSAL A KONUK N DEMIRER T KOC H
Citation: C. Ustun et al., WHICH HEMATOPOIETIC STEM-CELL TRANSPLANTATION TYPE IS SAFE FOR PATIENTS WITH HEPATITIS-B VIRUS CARRIERS, Hepatology, 28(4), 1998, pp. 2221-2221
FULMINANT-HEPATITIS IN APLASTIC-ANEMIA - HEPATITIS-G OR ALG
Authors: AKAN H KONUK N FENKCI S DILEK I IDILMAN R TUNCER S
Citation: H. Akan et al., FULMINANT-HEPATITIS IN APLASTIC-ANEMIA - HEPATITIS-G OR ALG, Bone marrow transplantation, 21(5), 1998, pp. 533-533
ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN LEUKEMIAS - A SINGLE-CENTER RESULTS
Authors: KOC H GURMAN G ARSLAN O USTUN C OZCAN M DILEK I AKAN H ILHAN O KONUK N UYSAL A BEKSAC M
Citation: H. Koc et al., ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN LEUKEMIAS - A SINGLE-CENTER RESULTS, Bone marrow transplantation, 21, 1998, pp. 39-39
ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS CAUSE MORE CHRONIC GRAFT-VERSUS-HOST DISEASE AND LESS RELAPSE COMPARED TO BONE-MARROW TRANSPLANTS
Authors: BEKSAC M USTUN C OZCAN M KOC H ILHAN O OZCELIK T DALVA K GURMAN G AKAN H ARAT M KONUK N UYSAL A
Citation: M. Beksac et al., ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS CAUSE MORE CHRONIC GRAFT-VERSUS-HOST DISEASE AND LESS RELAPSE COMPARED TO BONE-MARROW TRANSPLANTS, Bone marrow transplantation, 21, 1998, pp. 416-416
SERUM ERYTHROPOIETIN LEVELS IN PATIENTS WITH LEUKEMIA ON CYTOSTATIC TREATMENT
Authors: AYDOGDU I ILHAN O BEKSAC M KOC H AKAN H KONUK N UYSAL A
Citation: I. Aydogdu et al., SERUM ERYTHROPOIETIN LEVELS IN PATIENTS WITH LEUKEMIA ON CYTOSTATIC TREATMENT, Haematologia, 29(2), 1998, pp. 133-137
INCIDENCE OF TUBERCULOSIS AFTER BONE-MARROW TRANSPLANTATION IN A SINGLE-CENTER FROM TURKEY
Authors: ARSLAN O GURMAN G DILEK I OZCAN M KOC H ILHAN O AKAN H KONUK N UYSAL A BEKSAC M
Citation: O. Arslan et al., INCIDENCE OF TUBERCULOSIS AFTER BONE-MARROW TRANSPLANTATION IN A SINGLE-CENTER FROM TURKEY, Haematologia, 29(1), 1998, pp. 59-62
FLOW CYTOMETRIC G-CSF RECEPTOR EXPRESSION IN ACUTE MYELOID-LEUKEMIA AND ROLE IN G-CSF USE AT INDUCTION CHEMOTHERAPY
Authors: KUTLAY S BEKSAC M DALVA K ILHAN O KOC H AKAN H OZCAN M KONUK N UYSAL A
Citation: S. Kutlay et al., FLOW CYTOMETRIC G-CSF RECEPTOR EXPRESSION IN ACUTE MYELOID-LEUKEMIA AND ROLE IN G-CSF USE AT INDUCTION CHEMOTHERAPY, British Journal of Haematology, 102(1), 1998, pp. 87-87
RANDOMIZED UNICENTER TRIAL FOR COMPARISON OF 3 REGIMENS IN DE-NOVO ADULT ACUTE NONLYMPHOBLASTIC LEUKEMIA
Authors: BEKSAC M ARSLAP O KOC H AKAN H ILHAN O ARAT M OZCAN M GURMAN G KONUK N UYSAL A
Citation: M. Beksac et al., RANDOMIZED UNICENTER TRIAL FOR COMPARISON OF 3 REGIMENS IN DE-NOVO ADULT ACUTE NONLYMPHOBLASTIC LEUKEMIA, British Journal of Haematology, 102(1), 1998, pp. 220-220
INCIDENCE OF GRAFT-VS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION IN A SINGLE-CENTER STUDY FROM TURKEY
Authors: ILHAN O AKAN H KOC H GURMAN G ARSLAN O OZCAN M ERDI H ERDEM C KONUK N UYSAL A BEKSAC M
Citation: O. Ilhan et al., INCIDENCE OF GRAFT-VS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION IN A SINGLE-CENTER STUDY FROM TURKEY, HEM CELL TH, 39(3), 1997, pp. 133-136
ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION - IS THERE AN INCREASED RISK OF GRAFT-VS-HOST DISEASE IN LEUKEMIA PATIENTS
Authors: KOC H GURMAN G ARSLAN O OZCAN M DILEK I AKAN H ILHAN O KONUK N BEKSAC M UYSAL A
Citation: H. Koc et al., ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION - IS THERE AN INCREASED RISK OF GRAFT-VS-HOST DISEASE IN LEUKEMIA PATIENTS, Journal of chemotherapy, 9(5), 1997, pp. 371-376
HEMORRHAGIC CYSTITIS AS A COMPLICATION OF BONE-MARROW TRANSPLANTATION
Authors: ILHAN O KOC H AKAN H GURMAN G ARSLAN O OZCAN M ARIKAN N SENCER H KONUK N UYSAL A BEKSAC M
Citation: O. Ilhan et al., HEMORRHAGIC CYSTITIS AS A COMPLICATION OF BONE-MARROW TRANSPLANTATION, Journal of chemotherapy, 9(1), 1997, pp. 56-61
HLA DR2 - A PREDICTIVE MARKER IN RESPONSE TO CYCLOSPORINE THERAPY IN APLASTIC-ANEMIA
Authors: IHAN O BEKSAC M ARSLAN O OZCAN M KOC H AKAN H GURMAN G KONUK N UYSAL A
Citation: O. Ihan et al., HLA DR2 - A PREDICTIVE MARKER IN RESPONSE TO CYCLOSPORINE THERAPY IN APLASTIC-ANEMIA, International journal of hematology, 66(3), 1997, pp. 291-295
FEBRILE NEUTROPENIA IN A BONE-MARROW TRANSPLANTATION UNIT
Authors: AKAN H KOC H ARSLAN O BEKSAC M ILHAN O GURMAN G OZCAN M USTUN C KONUK N UYSAL A
Citation: H. Akan et al., FEBRILE NEUTROPENIA IN A BONE-MARROW TRANSPLANTATION UNIT, International journal of antimicrobial agents, 8(2), 1997, pp. 127-130
PROTEIN-C, PROTEIN-S, ANTITHROMBIN-III LEVELS AFTER HEMATOPOIETIC STEM-CELL TRANSPLANTATION
Authors: AKAR H OZCAN M ARSLAN O ILHAN O KOC H AKAN H GURMAN G DALVA K KONUK N UYSAL A BEKSAC M
Citation: H. Akar et al., PROTEIN-C, PROTEIN-S, ANTITHROMBIN-III LEVELS AFTER HEMATOPOIETIC STEM-CELL TRANSPLANTATION, Thrombosis and haemostasis, 1997, pp. 1706-1706
HEPATITIS-B VIRUS-INFECTION IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: USTUN C KOC H KARAYALCIN S AKYOL G GURMAN G ILHAN O AKAN H OZCAN M ARSLAN O KONUK N UYSAL A BEKSAC M
Citation: C. Ustun et al., HEPATITIS-B VIRUS-INFECTION IN ALLOGENEIC BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 20(4), 1997, pp. 289-296
ADMINISTRATION OF MINE PROTOCOL IN UNTREATED PATIENTS WITH INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA
Authors: AYDOGDU I KOC H ILHAN O GURMAN G AKAN H BEKSAC M KONUK N UYSAL A OZEROL E
Citation: I. Aydogdu et al., ADMINISTRATION OF MINE PROTOCOL IN UNTREATED PATIENTS WITH INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA, Haematologia, 28(4), 1997, pp. 207-213
CLINICAL RELEVANCE OF FLOW CYTOMETRIC BCL-2 AND CD95 EXPRESSION IN ACUTE MYELOID-LEUKEMIA
Authors: KUTLAY S BEKSAC M DALVA K ILHAN O AKAN H KOC H OZCAN M KONUK N UYSAL A
Citation: S. Kutlay et al., CLINICAL RELEVANCE OF FLOW CYTOMETRIC BCL-2 AND CD95 EXPRESSION IN ACUTE MYELOID-LEUKEMIA, Blood, 90(10), 1997, pp. 3709-3709
A RANDOMIZED SINGLE INSTITUTIONAL STUDY ON COMPARISON OF IDARUBICIN (I) VERSUS DAUNORUBICIN (D) VERSUS MITOXANTRONE (M) CONTAINING INDUCTION AND CONSOLIDATION REGIMENS IN ACUTE MYELOBLASTIC-LEUKEMIA (AML)
Authors: BEKSAC M ARSLAN O KOC H AKAN H ILHAN O ARAT M OZCAN M GURMAN G KONUK N UYSAL A
Citation: M. Beksac et al., A RANDOMIZED SINGLE INSTITUTIONAL STUDY ON COMPARISON OF IDARUBICIN (I) VERSUS DAUNORUBICIN (D) VERSUS MITOXANTRONE (M) CONTAINING INDUCTION AND CONSOLIDATION REGIMENS IN ACUTE MYELOBLASTIC-LEUKEMIA (AML), Blood, 90(10), 1997, pp. 3806-3806
DONOR LEUKOCYTE INFUSIONS FOR THE TREATMENT OF LEUKEMIA RELAPSE AFTERALLOGENEIC HEMATOPOIETIC PROGENITOR-CELL TRANSPLANTATION
Authors: GURMAN G ARSLAN O KOC H DILEK I USTUN C OZCAN M AKAN H ILHAN O SUNGUROGLU A KONUK N UYSAL A IDILMAN R BEKSAC M
Citation: G. Gurman et al., DONOR LEUKOCYTE INFUSIONS FOR THE TREATMENT OF LEUKEMIA RELAPSE AFTERALLOGENEIC HEMATOPOIETIC PROGENITOR-CELL TRANSPLANTATION, Blood, 90(10), 1997, pp. 4452-4452
USE OF HIGH-DOSE CHEMOTHERAPY PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR FOR THE SALVAGE OF REFRACTORY OR RESISTANT-RELAPSE LYMPHOMA PATIENTS WITHOUT STEM-CELL SUPPORT
Authors: KOC H ARSLAN O AKAN H OZCAN M ILHAN O AYDOGDU I ARAT M BEKSAC M KONUK N UYSAL A
Citation: H. Koc et al., USE OF HIGH-DOSE CHEMOTHERAPY PLUS GRANULOCYTE-COLONY-STIMULATING FACTOR FOR THE SALVAGE OF REFRACTORY OR RESISTANT-RELAPSE LYMPHOMA PATIENTS WITHOUT STEM-CELL SUPPORT, Acta haematologica, 98(3), 1997, pp. 136-139
LACK OF PROGNOSTIC VALUE OF CD34 IN ADULT AML
Authors: ARSLAN O AKAN H BEKSAC M OZCAN M KOC H ILHAN O KONUK N UYSAL A
Citation: O. Arslan et al., LACK OF PROGNOSTIC VALUE OF CD34 IN ADULT AML, Leukemia & lymphoma, 23(1-2), 1996, pp. 185-186
EOSINOPHILIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION USING BUSULFAN AND CYCLOPHOSPHAMIDE CONDITIONING REGIMEN
Authors: ARSLAN O AKAN H KOC H BEKSAC M ILHAN O OZCAN M YALCIN S GURMAN G KONUK N UYSAL A
Citation: O. Arslan et al., EOSINOPHILIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION USING BUSULFAN AND CYCLOPHOSPHAMIDE CONDITIONING REGIMEN, Bone marrow transplantation, 18(1), 1996, pp. 261-261
IS THERE AN INCREASED RISK OF GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION
Authors: KOC H GURMAN G ARSLAN O OZCAN M AKAN H ILHAN O KONUK N BEKSAC M UYSAL A
Citation: H. Koc et al., IS THERE AN INCREASED RISK OF GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, Blood, 88(6), 1996, pp. 2362-2364
HEMORRHAGIC CYSTITIS AFTER BONE-MARROW TRANSPLANTATION - THE ROLE OF ELECTRON-MICROSCOPY IN DIFFERENTIAL-DIAGNOSIS
Authors: GURMAN G SENCER H UYSAL A CINAR K ARSLAN O OZCAN M KOC H AKAN H BEKSAC M ILHAN O TORUNER M KONUK N
Citation: G. Gurman et al., HEMORRHAGIC CYSTITIS AFTER BONE-MARROW TRANSPLANTATION - THE ROLE OF ELECTRON-MICROSCOPY IN DIFFERENTIAL-DIAGNOSIS, Blood, 88(10), 1996, pp. 3747-3747
CD34 CELL DOSE INFLUENCES HEMATOLOGICAL RECOVERY AFTER PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION
Authors: ILHAN O BEKSAC M ARSLAN O AKAN H KOC H DILEK I ARAT M OZCAN M GURMAN G KONUK N UYSAL A
Citation: O. Ilhan et al., CD34 CELL DOSE INFLUENCES HEMATOLOGICAL RECOVERY AFTER PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION, Blood, 88(10), 1996, pp. 3751-3751
Risultati: 1-25 | 26-35